Variant report

Variant	rs6432214
Chromosome Location	chr2:11694676-11694677
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAX	chr2:11694288-11694813	NB4	blood:	n/a	n/a
2	POLR2A	chr2:11693148-11694987	MCF-7	breast:	n/a	n/a
3	POLR2A	chr2:11694124-11694938	HepG2	liver:	n/a	n/a
4	YY1	chr2:11694524-11694773	GM12892	blood:	n/a	n/a
5	POLR2A	chr2:11694620-11694809	GM12878	blood:	n/a	n/a
6	SPI1	chr2:11694268-11694763	HL-60	blood:	n/a	n/a
7	MYC	chr2:11694250-11694775	NB4	blood:	n/a	n/a
8	YY1	chr2:11694641-11694844	GM12892	blood:	n/a	chr2:11694771-11694779

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:11693244..11695539-chr2:11699023..11701494,2	K562	blood:
2	chr2:11694156..11696211-chr2:11713975..11716085,2	K562	blood:

Variant related genes	Relation type
GREB1	TF binding region
ENSG00000251718	Chromatin interaction

Extended variants
information (count: 22 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:18)

rs_ID	r²[population]
rs10495583	0.88[CEU][hapmap]
rs4313952	1.00[CEU][hapmap];0.88[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4669751	0.82[CHB][hapmap];0.84[CHD][hapmap];0.82[GIH][hapmap];0.86[JPT][hapmap];0.86[ASN][1000 genomes]
rs5020877	0.90[CEU][hapmap]
rs6432210	1.00[ASW][hapmap];1.00[CEU][hapmap];0.88[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.97[LWK][hapmap];1.00[MEX][hapmap];0.98[MKK][hapmap];1.00[TSI][hapmap];0.91[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs6432211	1.00[CEU][hapmap];0.88[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.94[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6432212	1.00[ASW][hapmap];1.00[CEU][hapmap];0.88[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6432213	1.00[CEU][hapmap];0.88[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6432215	1.00[CEU][hapmap];0.88[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6432216	1.00[CEU][hapmap];0.82[CHB][hapmap];0.87[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs6432219	0.87[ASN][1000 genomes]
rs6718650	0.80[CEU][hapmap]
rs6745409	0.80[CEU][hapmap]
rs6749404	1.00[CEU][hapmap];0.88[CHB][hapmap];1.00[JPT][hapmap];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs73191479	0.94[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs7565567	0.82[CHB][hapmap];0.86[JPT][hapmap];0.82[ASN][1000 genomes]
rs930310	1.00[CEU][hapmap];0.88[CHB][hapmap];0.94[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9784028	0.80[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1010506	chr2:11430965-12057286	Enhancers Strong transcription Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
2	nsv535585	chr2:11430965-12057286	Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription ZNF genes & repeats Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
3	nsv873663	chr2:11664349-11783775	Genic enhancers Weak transcription ZNF genes & repeats Strong transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	41 gene(s)	inside rSNPs	diseases
4	esv1814335	chr2:11689048-11718858	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:44 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:11678400-11757000	Weak transcription	Right Ventricle	heart
2	chr2:11683400-11697800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
3	chr2:11688600-11696400	Weak transcription	Pancreas	Pancrea
4	chr2:11690000-11711000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr2:11691000-11694800	Genic enhancers	HepG2	liver
6	chr2:11691000-11697600	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr2:11691400-11696200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr2:11691400-11697600	Weak transcription	H1 Cell Line	embryonic stem cell
9	chr2:11691400-11699800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr2:11693200-11695000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
11	chr2:11693600-11694800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
12	chr2:11693800-11694800	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr2:11693800-11694800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr2:11693800-11694800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr2:11693800-11694800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr2:11693800-11694800	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr2:11694000-11694800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr2:11694000-11694800	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr2:11694000-11694800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
20	chr2:11694000-11694800	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
21	chr2:11694000-11694800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr2:11694000-11694800	Transcr. at gene 5' and 3'	Ovary	ovary
23	chr2:11694000-11694800	Bivalent Enhancer	HSMMtube	muscle
24	chr2:11694000-11694800	Bivalent Enhancer	Osteobl	bone
25	chr2:11694000-11695000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr2:11694200-11694800	Flanking Active TSS	Primary hematopoietic stem cells	blood
27	chr2:11694200-11694800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr2:11694200-11694800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr2:11694200-11694800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr2:11694200-11694800	Enhancers	Fetal Lung	lung
31	chr2:11694200-11694800	Enhancers	Gastric	stomach
32	chr2:11694200-11694800	Enhancers	GM12878-XiMat	blood
33	chr2:11694200-11694800	Bivalent Enhancer	HMEC	breast
34	chr2:11694200-11695800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr2:11694200-11698400	Weak transcription	H9 Cell Line	embryonic stem cell
36	chr2:11694200-11698400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr2:11694400-11694800	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr2:11694400-11694800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr2:11694600-11694800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr2:11694600-11694800	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr2:11694600-11694800	Bivalent Enhancer	HSMM	muscle
42	chr2:11694600-11694800	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
43	chr2:11694600-11696200	Enhancers	Brain Substantia Nigra	brain
44	chr2:11694600-11698200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links